Urgent.News

What's breaking now, across hundreds of outlets.

Health & Medicine

Ho Chi Minh City Oncology Hospital signs MoU with Novartis Vietnam

Ho Chi Minh City Oncology Hospital and Novartis Vietnam have signed an MoU for a strategic partnership aimed at strengthening cancer treatment and patient care in Vietnam

Ho Chi Minh City Oncology Hospital signs MoU with Novartis Vietnam

On October 5, Ho Chi Minh City Oncology Hospital (HOH) signed a memorandum of understanding (MoU) with Novartis Vietnam for the period of 2026-2028. The event was attended by Ho Chi Minh City Oncology Hospital director, Dr. Diep Bao Tuan, and Novartis Vietnam general director, Jondy Syjuco, along with representatives from both organizations.

Vietnam faces a significant cancer health challenge, making this partnership increasingly crucial. The agreement aims to enhance cancer care and treatment by improving professional capabilities, institutional excellence, and patient education. Novartis Vietnam and HOH have agreed to collaborate in three key areas: strengthening healthcare professional capacity, advancing HOH as a central hub in the healthcare network, and organizing patient-oriented programs.

Firstly, they will enhance healthcare professional capacity through continuing medical education programs, scientific conferences, and symposia. These initiatives will facilitate knowledge exchange and clinical practice, keeping healthcare professionals updated on evolving clinical evidence in cancer care. Secondly, HOH will become a central hub in the healthcare network, training lower-level hospitals to improve cancer care quality across all care tiers.

This will strengthen treatment quality at provincial hospitals and enable earlier, more accurate diagnoses for patients. Thirdly, both parties will collaborate on patient-oriented programs, including online consultations, cancer awareness education, and early-detection initiatives. These activities aim to empower patients and caregivers with knowledge and tools to manage treatment-related adverse effects.

Dr. Diep Bao Tuan expressed excitement about the new collaboration, emphasizing ongoing medical education, professional development, research strengthening, and patient-oriented initiatives. Jondy Syjuco highlighted Novartis Vietnam's commitment to advancing healthcare through professional capability development, research, and patient engagement.

The signing ceremony is particularly significant as it marks Novartis' 30-year commitment to global healthcare advancements. As a long-term partner of Vietnam's healthcare system, Novartis affirms its ongoing commitment to building a more capable cancer-care network that meets patient needs and supports broader efforts to elevate Vietnam's healthcare system.

Rewritten by urgent.news; may contain errors — check the original.

Read the original at vir.com.vn →

More in Health & Medicine

More from Wednesday 7 October →